Opening new doors to combat bacterial infections
We may be several steps closer to understanding one of the major pathologies that affects sufferers of cystic fibrosis, thanks to Senior researcher Eduard Torrents of IBEC’s Microbial biotechnology and host-pathogen interaction group.
In a study published this week in the American Society for Microbiology’s journal Infection and Immunity, Eduard and his collaborator in Stockholm, Britt-Marie Sjöberg, looked at DNA synthesis in Pseudomonas aeruginosa, a bacterial infection that is a frequent complication in many people with cystic fibrosis, and a common cause of death in those patients.